Skip to main content
$1.32 $0.09 (7.3%)

04:00 PM EST on 12/01/23

Heron Therapeutics, Inc. (NASDAQ:HRTX)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.

Current Price $1.32 Mkt Cap $198.1M
Open $1.23 P/E Ratio -1.37
Prev. Close $1.32 Div. (Yield) $0.00 (0.0%)
Daily Range $1.16 - $1.34 Volume 290
52-Wk Range $0.50 - $3.41 Avg. Daily Vol. 2,892,370

Caps

How do you think NASDAQ:HRTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

28 Outperform
11 Underperform
 

All-Star Players

6 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:HRTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

zzlangerhans (98.77)
Submitted May 31, 2015

I shorted 1000 shares of Heron with a cost basis of 17.22 in the after hours after the company reported positive topline data from the MAGIC phase III of Sustol for highly emetogenic chemotherapy. I didn't think the initial gains were sustainable… More

Fools bullish on NASDAQ:HRTX are also bullish on:

Fools bearish on NASDAQ:HRTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about HRTX.

Recs

0
Member Avatar NCMichael (< 20) Submitted: 7/12/2019 1:10:46 PM : Outperform Start Price: $18.60 NASDAQ:HRTX Score: -145.93

Once the fda arrives their brew product, the stock will do very well.

Recs

0
Member Avatar pisspoorpicks (20.96) Submitted: 2/20/2013 1:44:48 AM : Outperform Start Price: $14.80 NASDAQ:HRTX Score: -292.39

03/27/2013 PDUFA of APF530 for prevention of acute and delayed onset chemotherapy induced nausea and vomiting.

Leaderboard

Find the members with the highest scoring picks in HRTX.

Score Leader

IdahoInvestor

IdahoInvestor (99.66) Score: +336.14

The Score Leader is the player with the highest score across all their picks in HRTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
IdahoInvestor 99.66 11/14/2012 Underperform 5Y $10.80 -87.78% +234.33% +322.11 0 Comment
sinvestor 72.18 1/14/2014 Underperform 3M $10.00 -86.80% +151.87% +238.67 0 Comment
MMCapitalMgmt 95.90 9/1/2015 Underperform 5Y $37.30 -96.46% +137.73% +234.19 0 Comment
OregonState < 20 9/2/2015 Underperform 5Y $37.01 -96.43% +135.90% +232.33 0 Comment
rjanina41 < 20 2/22/2016 Underperform 3M $18.19 -92.74% +136.81% +229.55 0 Comment
ziggystraw 90.93 11/23/2015 Underperform 5Y $25.77 -94.88% +119.27% +214.14 0 Comment
km00nster < 20 6/1/2015 Underperform 5Y $21.14 -93.76% +116.62% +210.37 0 Comment
johnnyrocku 99.75 6/1/2015 Underperform 5Y $19.60 -93.27% +116.96% +210.22 0 Comment
Momentum21 34.30 4/5/2018 Underperform 5Y $28.55 -95.38% +72.38% +167.76 0 Comment
WildShaman 78.47 7/9/2018 Underperform 5Y $40.85 -96.77% +66.01% +162.78 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for HRTX.